Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 4.9T | 4.9T | 5.0T | 4.6T |
Cost of revenue | 4.1T | 4.1T | 4.2T | 3.9T |
Gross profit | 796.1B | 828.8B | 802.4B | 700.2B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 182.3B | 226.9B | 161.8B | 164.7B |
Other operating expenses | 22.2B | 75.6B | 40.9B | 17.0B |
Operating income | 308.5B | 213.4B | 320.4B | 231.9B |
Non operating interest income | ||||
Income | 56.2B | 61.3B | 56.7B | 41.6B |
Expense | 11.5B | 10.7B | 11.4B | 9.9B |
Other income expense | — | — | — | — |
Pretax income | 605.6B | 640.6B | 641.6B | 628.2B |
Tax provision | 74.7B | 89.6B | 79.5B | 69.3B |
Net income | 530.8B | 550.9B | 562.1B | 558.8B |
Basic EPS | 105 | — | — | — |
Diluted EPS | 105 | — | — | — |
Basic average shares | 4.8B | — | — | — |
Diluted average shares | 4.8B | — | — | — |
EBITDA | 655.9B | 690.5B | 689.8B | 510.9B |
Net income from continuing op. | — | — | — | — |
Minority interests | -25.2B | -45.6B | -47.5B | -20.1B |
Preferred stock dividends | 0 | 0 | 0 | 0 |